Science
Mechanism of Action
This complex peptide acts as both a skin conditioning and protecting agent. By mimicking the skin's natural repair processes, it stimulates the proliferation and growth of dermal cells, particularly fibroblasts, which are critical for boosting endogenous collagen and elastin production. A key component, sh-Polypeptide-11 (a recombinant acidic Fibroblast Growth Factor analog), drives this cellular growth and structural reinforcement. Additionally, it exhibits potent antioxidant capabilities, effectively reducing free radicals and inhibiting cellular aging.
Research
Clinical Evidence
Low confidenceN/A
Transparency
Dusting Analysis
The Formula
Formulation
Stability
Due to the substantial molecular size of its sh-Polypeptide-11 component, encapsulation in carrier systems like lipid spheres or liposomes may be necessary to facilitate optimal penetration through the stratum corneum and ensure effective action in deeper skin layers. For its Hexapeptide-11 component, it is advisable to incorporate into the aqueous phase of formulations at temperatures maintained below 40°C.
Safety
Safety Profile
RH-POLYPEPTIDE-11 DIPEPTIDE-19 OLIGOPEPTIDE-91 HEXAPEPTIDE-40 is classified as a 'PROHIBITED INGREDIENT' by the EU under restriction II/416. There is no specific safety assessment by the Cosmetic Ingredient Review (CIR) or the FDA for this exact ingredient. While a related ingredient, Sr-(Hexapeptide-40 Oligopeptide-91 Clostridium Botulinum Polypeptide-1), is generally considered safe for topical application, data for pregnant or breastfeeding individuals is lacking, recommending professional healthcare consultation.
Your Skin
Skin Compatibility
Our Assessment
Verdict
Despite its promising mechanistic profile for advanced skin regeneration and protection, RH-POLYPEPTIDE-11 DIPEPTIDE-19 OLIGOPEPTIDE-91 HEXAPEPTIDE-40 is strictly prohibited for cosmetic use in the EU, rendering its inclusion in formulations unfeasible.
Related
Similar Ingredients
Finding similar ingredients…